These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36716877)

  • 1. Identification of biomarkers for risk assessment of arsenicosis based on untargeted metabolomics and machine learning algorithms.
    Zhang J; Ma L; Li B; Chen X; Wang D; Zhang A
    Sci Total Environ; 2023 Apr; 870():161861. PubMed ID: 36716877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined metabolomics and machine learning algorithms to explore metabolic biomarkers for diagnosis of acute myocardial ischemia.
    Cao J; Li J; Gu Z; Niu JJ; An GS; Jin QQ; Wang YY; Huang P; Sun JH
    Int J Legal Med; 2023 Jan; 137(1):169-180. PubMed ID: 35348878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study on early postmortem submersion interval (PMSI) estimation and cause-of-death discrimination based on nontargeted metabolomics and machine learning algorithms.
    Zhang FY; Wang LL; Dong WW; Zhang M; Tash D; Li XJ; Du SK; Yuan HM; Zhao R; Guan DW
    Int J Legal Med; 2022 May; 136(3):941-954. PubMed ID: 35099605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection.
    Li J; Liu K; Ji Z; Wang Y; Yin T; Long T; Shen Y; Cheng L
    Cancer Sci; 2023 Feb; 114(2):680-689. PubMed ID: 36310111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.
    Wang M; Li R; Qi H; Pang L; Cui L; Liu Z; Lu J; Wang R; Hu S; Liang N; Tao Y; Dalbeth N; Merriman TR; Terkeltaub R; Yin H; Li C
    Arthritis Rheumatol; 2023 Dec; 75(12):2252-2264. PubMed ID: 37390372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
    Gu Y; Zang P; Li J; Yan Y; Wang J
    Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics and machine learning approaches for diagnostic and prognostic biomarkers screening in sepsis.
    She H; Du Y; Du Y; Tan L; Yang S; Luo X; Li Q; Xiang X; Lu H; Hu Y; Liu L; Li T
    BMC Anesthesiol; 2023 Nov; 23(1):367. PubMed ID: 37946144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.
    Shen X; Wang C; Liang N; Liu Z; Li X; Zhu ZJ; Merriman TR; Dalbeth N; Terkeltaub R; Li C; Yin H
    Arthritis Rheumatol; 2021 Sep; 73(9):1738-1748. PubMed ID: 33760368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning of plasma metabolome identifies biomarker panels for metabolic syndrome: findings from the China Suboptimal Health Cohort.
    Wang H; Wang Y; Li X; Deng X; Kong Y; Wang W; Zhou Y
    Cardiovasc Diabetol; 2022 Dec; 21(1):288. PubMed ID: 36564831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
    Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
    Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of arsenic levels in arsenicosis residents and awareness of its risk factors: A population-based 20-year follow-up study in a unique coal-borne arsenicosis County in Guizhou, China.
    Wang D; Luo P; Zou Z; Wang Q; Yao M; Yu C; Wei S; Sun B; Zhu K; Zeng Q; Li J; Liang B; Zhang A
    Environ Int; 2019 Aug; 129():18-27. PubMed ID: 31102951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
    Guo M; Zhang J
    Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association and risk of circulating inflammatory markers with hyperglycemia in coal-burning arsenicosis.
    Liu Y; Wang W; Zou Z; Sun B; Liang B; Zhang A
    Ecotoxicol Environ Saf; 2022 Dec; 247():114208. PubMed ID: 36279635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
    Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
    Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight from untargeted metabolomics: Revealing the potential marker compounds changes in refrigerated pork based on random forests machine learning algorithm.
    Gu M; Li C; Chen L; Li S; Xiao N; Zhang D; Zheng X
    Food Chem; 2023 Oct; 424():136341. PubMed ID: 37216778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity.
    Ning P; Zheng Y; Luo Q; Liu X; Kang Y; Zhang Y; Zhang R; Xu Y; Yang D; Xi W; Wang K; Chen Y; An S; Gao Z
    Crit Care; 2018 May; 22(1):130. PubMed ID: 29759075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
    Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J
    Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.